Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms.

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid tablets.

The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.

A study reveals Benralizumab as a new treatment for asthma and COPD, reducing treatment failure rates significantly.

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%.

The first new treatment for asthma attacks in 50 years may be a “game-changer”, researchers say. Offering patients an injection is more effective than the current care of steroid tablets and cuts the need for further treatment by 30 per cent, according to a study.

Researchers say they have found the first new treatment for asthma attacks in 50 years. The injection dampens part of the immune system that can go into overdrive in flare-ups of both asthma and a lung condition called chronic obstructive pulmonary disease (COPD).

Benralizumab is what’s known as a monoclonal antibody, which replicates properties of a normal antibody produced by the immune system. The antibody targets a specific group of white blood cells (called eosinophils) to reduce lung inflammation.

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation.